Has the latest Aussie retail sales data locked in an RBA interest rate cut in February?

Will Aussie investors enjoy lower interest rates in February following the latest retail sales print?

Magnifying glass on percentage signs.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) investors have been patiently awaiting the first interest rate cut from The Reserve Bank of Australia for more than four years now.

The last time the RBA lowered rates was way back in November 2020, when the central bank slashed the official cash rate to the historic low 0.10%.

At the central bank's most recent meeting on 10 December, the board left interest rates on hold at the current 4.35%. That's the highest level since November 2011.

As of Friday, ASX 200 investors appeared very optimistic on a February cut. According to the RBA Rate Indicator, money markets have priced in a 95% chance the RBA will ease rates to 4.10% when it next meets on 18 February.

Here's how Australia's latest retail sales data may impact those odds.

What's happening with Aussie retail sales?

According to the seasonally adjusted figures released earlier today by the Australian Bureau of Statistics (ABS), Australian retail turnover fell 0.1% in December.

That's a lot stronger than the 0.7% decline economists had widely expected, and as we'll look at below, it could bolster the case for a February RBA interest rate cut.

December's 0.1% dip in retail spending data follows November's 0.7% growth and October's 0.5% increase.

Commenting on the results, Robert Ewing, ABS head of business statistics, said:

Retail spending held firm following strong growth in recent months with promotional activity stretched across the quarter.

Cyber Monday fell in early December and boosted spending to begin the month, particularly on discretionary items like furniture, homewares, electronics and electrical items.

On a quarterly basis, retail sales increased 1.0% (seasonally adjusted) in the December quarter, exceeding consensus estimates of 0.8% quarterly growth.

"Retail sales volumes rose for the second straight quarter, boosted by continuous promotional activity," Ewing said.

"Sales events throughout the quarter like Black Friday and Cyber Monday saw more discretionary spending on things like furniture, electronic goods and clothing," he added.

The ASX 200 remains down 1.6% at the time of writing as the market assesses the potential impacts of US President Donald Trump's sweeping tariffs on Mexico, Canada and China. But with investors possibly buoyed by rising odds of a February RBA interest rate cut, the ASX 200 has gained 0.4% since the ABS released the December retail sales data.

Will the RBA cut interest rates in February?

ASX 200 investors and mortgage holders will be closely monitoring the RBA's interest rate decision on 18 February.

And the latest batch of retail sales data looks likely to increase the odds that a rate cut will finally come through, as the RBA steers the Aussie economy to a so-called 'soft landing' following years of excess inflation.

According to Capital Economics (courtesy of The Australian Financial Review), the latest retail sales data is unlikely to discourage the RBA from easing interest rates later this month.

Though Capital Economics Australia economist Abhijit Surya noted the RBA may remain cautious.

According to Surya:

There continues to be uncertainty about whether the strong retail trade data reflect a sustained recovery in consumer demand or merely a 'pull-forward' in expenditure in response to emerging patterns of promotional activity.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Three small children reach up to hold a toy rocket high above their heads in a green field with a blue sky above them.
Growth Shares

These 4 ASX 200 stocks could jump another 70% to 80% in 2026

These stocks are expected to rocket higher.

Read more »

Two excited woman pointing out a bargain opportunity on a laptop.
Share Gainers

3 ASX 200 stocks jumping higher in this week's falling market

Investors shrugged off the broader market retrace and piled into these three ASX 200 stocks this week.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why EOS, Lotus Resources, REA, and Web Travel shares are dropping today

These shares are ending the week deep in the red. But why?

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Gainers

Why Brambles, HMC Capital, ResMed, and Rio Tinto shares are rising today

These shares are avoiding the selloff and are pushing higher on Friday.

Read more »

A woman looks shocked as she drinks a coffee while reading the paper.
Share Fallers

Why is the Web Travel share price crashing 41% on Friday?

ASX investors are pummelling Web Travel shares today. But why?

Read more »

A man looking at his laptop and thinking.
Materials Shares

Rio Tinto shares charge higher after Glencore merger collapses

The parties couldn't come to an agreement.

Read more »

a group of doctors and medical staff in uniform high five in celebration in a hospital setting
Share Market News

Neuren Pharmaceuticals kicks off Phase 3 trial in rare syndrome

Neuren Pharmaceuticals shares are on watch after dosing began in its key Phase 3 trial for Phelan-McDermid syndrome.

Read more »